In Reply
Obstet Gynecol
.
2020 Aug;136(2):427-428.
doi: 10.1097/AOG.0000000000004032.
Authors
Mona Prasad
1
,
George Saade
2
,
Brenna Hughes
3
Affiliations
1
Department of Obstetrics and Gynecology, The Ohio State University, Columbus, Ohio.
2
University of Texas Medical Branch at Galveston, Galveston, Texas.
3
Brown University, Providence, Rhode Island.
PMID:
32732757
PMCID:
PMC9040923
DOI:
10.1097/AOG.0000000000004032
No abstract available
Publication types
Comment
MeSH terms
Antibodies*
Cohort Studies
Female
Hepacivirus*
Humans
Pregnancy
Risk Factors
Seroepidemiologic Studies
Substances
Antibodies
Grants and funding
U10 HD040500/HD/NICHD NIH HHS/United States
U10 HD068268/HD/NICHD NIH HHS/United States
U10 HD040544/HD/NICHD NIH HHS/United States
UG1 HD040560/HD/NICHD NIH HHS/United States
U10 HD040485/HD/NICHD NIH HHS/United States
U10 HD034116/HD/NICHD NIH HHS/United States
U10 HD027869/HD/NICHD NIH HHS/United States
U10 HD040560/HD/NICHD NIH HHS/United States
UG1 HD040500/HD/NICHD NIH HHS/United States
U10 HD040512/HD/NICHD NIH HHS/United States
U10 HD040545/HD/NICHD NIH HHS/United States
U01 HD036801/HD/NICHD NIH HHS/United States
U10 HD027915/HD/NICHD NIH HHS/United States
U10 HD068282/HD/NICHD NIH HHS/United States
UG1 HD040545/HD/NICHD NIH HHS/United States
U10 HD034208/HD/NICHD NIH HHS/United States
U10 HD053097/HD/NICHD NIH HHS/United States
U10 HD068258/HD/NICHD NIH HHS/United States